MedDataX Logo

Systems Biology of Gastrointestinal and Related Diseases

NCT ID: NCT05579444

Last Updated: 2023-12-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

17 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-11-11

Study Completion Date

2023-11-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a longitudinal observational study on patients with gastrointestinal and related disease. The study will be conducted for at least 10 years, following each participant over time, as they either go through relapses and remissions, or progression of their disease.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a longitudinal, observational study whose main goal is to identify the human and microbial determinants of gastrointestinal diseases. Molecular and metadata will be collected from a large study population at multiple time points. Machine learning will be applied to all data, and models will be evaluated for development of novel diagnostic and therapeutic tools.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ulcerative Colitis Crohn Disease Obesity Colon Polyp Eosinophilic Esophagitis GERD Gastro Esophageal Reflux Barrett Esophagus Esophageal Cancer Gastritis Gastric Ulcer Duodenal Ulcer Intestinal Metaplasia Gastric Cancer Lymphocytic Colitis Microscopic Colitis Celiac Sprue IBS Irritable Bowel Syndrome SIBO NAFLD Gallstone Disease

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

gastrointestinal disease gastric upset

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ulcerative Colitis

Participants with ulcerative colitis.

No interventions assigned to this group

Crohn's Disease

Participants with Crohn's disease.

No interventions assigned to this group

Obesity

Participants that are obese.

No interventions assigned to this group

Colon Polyps

Participants with colon polyps.

No interventions assigned to this group

Eosinophilic esophagitis

Participants with Eosinophilic esophagitis

No interventions assigned to this group

Gastroesophageal Reflux Disease (GERD)

Participants with Gastroesophageal Reflux Disease (GERD).

No interventions assigned to this group

Gastritis

Participants with gastritis.

No interventions assigned to this group

Gastric ulcers

Participants with gastric ulcers.

No interventions assigned to this group

Duodenal ulcers

Participants with duodenal ulcers.

No interventions assigned to this group

Intestinal metaplasia

Participants with intestinal metaplasia (risk factor for esophageal cancer).

No interventions assigned to this group

Gastric Cancer

Participants with gastric cancer.

No interventions assigned to this group

Lymphocytic/Microscopic Colitis

Participants with Lymphocytic/Microscopic Colitis.

No interventions assigned to this group

Celiac Sprue

Participants with Celiac Sprue.

No interventions assigned to this group

Irritable Bowel Syndrome (IBS)

Participants with IBS.

No interventions assigned to this group

Small intestinal bacterial overgrowth (SIBO)

Participants with SIBO.

No interventions assigned to this group

Non-alcoholic Fatty Liver Disease (NAFLD)

Participants with NAFLD.

No interventions assigned to this group

Gallstone disease

Participants with Gallstone disease.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patient 18 years old or older that schedules a visit to WAGI clinics or endoscopy center
* Able to use electronic communications
* Able to communicate in English
* Consent to participate in the study

Exclusion Criteria

* None
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Viome

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Momchilo Vuyisich

Role: PRINCIPAL_INVESTIGATOR

Viome

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Viome Life Sciences

Bothell, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

V263

Identifier Type: -

Identifier Source: org_study_id